Patents by Inventor James D. Thompson

James D. Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6492512
    Abstract: An enzymatic RNA molecule which cleaves mRNA associated with development or maintenance of lung cancer.
    Type: Grant
    Filed: August 26, 1992
    Date of Patent: December 10, 2002
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: James D. Thompson, Kenneth G. Draper
  • Publication number: 20020168974
    Abstract: A system and method for adjusting satellite communication signal transmit power for signals transmitted to a localized region within a satellite coverage area utilize real-time information on weather conditions (172) and/or actual path losses (174) within the localized regions to adjust the effective isotropic radiated power (EIRP) of the satellite beams (188) to minimize the total radio frequency (RF) power required for transmission. The transmission system may be realized using a variety of antenna types for transmitting spot beams and/or area coverage beams. Representative antenna implementations include multi-beam antennas having a low-level beamforming network and hybrid matrix amplifier system, phased-array with independent input amplitude control and beamsteering for each beam, and a phased-array feeding a confocal imaging system for single broadcast beam per polarization.
    Type: Application
    Filed: February 6, 2002
    Publication date: November 14, 2002
    Inventors: Harold A. Rosen, Todd K. Citron, Steven O. Lane, James D. Thompson, Arnold L. Berman, Robert E. Vaughan
  • Patent number: 6448009
    Abstract: Nucleic acid catalysts, method of screening/selection for nucleic acid catalysts, synthesis of ribozyme libraries and discovery of gene sequences involved in a biological process are described.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: September 10, 2002
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventor: James D. Thompson
  • Patent number: 6438354
    Abstract: A reconfigurable payload for a satellite having a flexible antenna system, a variable downconverter technology and a filter technology that all work in combination to allow the payload of a satellite to be reconfigured in orbit.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: August 20, 2002
    Assignee: Hughes Electronics Corporation
    Inventors: James D. Thompson, Parthasarathy Ramanujam, Cynthia A. Dixon, Debbie H. Feuerborn, David R. Goldberg, Stephen F. Sichi, Lomash J. Shah, John R. Dunwoody
  • Patent number: 6421528
    Abstract: A system and method for adjusting satellite communication signal transmit power for signals transmitted to a localized region within a satellite coverage area utilize real-time information on weather conditions (172) and/or actual path losses (174) within the localized regions to adjust the effective isotropic radiated power (EIRP) of the satellite beams (188) to minimize the total radio frequency (RF) power required for transmission. The transmission system may be realized using a variety of antenna types for transmitting spot beams and/or area coverage beams. Representative antenna implementations include multi-beam antennas having a low-level beamforming network and hybrid matrix amplifier system, phased-array with independent input amplitude control and beamsteering for each beam, and a phased-array feeding a confocal imaging system for single broadcast beam per polarization.
    Type: Grant
    Filed: April 29, 1999
    Date of Patent: July 16, 2002
    Assignee: Hughes Electronics Corp.
    Inventors: Harold A. Rosen, Todd K. Citron, Steven O. Lane, James D. Thompson, Arnold L. Berman, Robert E. Vaughan
  • Publication number: 20010034206
    Abstract: A reconfigurable payload for a satellite having a flexible antenna system, a variable downconverter technology and a filter technology that all work in combination to allow the payload of a satellite to be reconfigured in orbit.
    Type: Application
    Filed: December 23, 1998
    Publication date: October 25, 2001
    Applicant: THOMPSON, JAMES D.
    Inventors: JAMES D. THOMPSON, PARTHASARATHY RAMANUJAM, CYNTHIA A. DIXON, DEBBIE H. FEUERBON, DAVID R. GOLDBERG, STEPHEN SICHI, LOMASH SHAH, JOHN DUNWOODY
  • Patent number: 6183959
    Abstract: Nucleic acid catalysts, method of screening/selection for nucleic acid catalysts, synthesis of ribozyme libraries and discovery of gene sequences involved in a biological process are described.
    Type: Grant
    Filed: July 8, 1998
    Date of Patent: February 6, 2001
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventor: James D. Thompson
  • Patent number: 6159692
    Abstract: An enzymatic nucleic acid molecule which cleaves an immunodeficiency virus RNA in a gene required for viral replication, e.g., the nef or tat gene regions.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: December 12, 2000
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Kenneth G. Draper, Bharat Chowrira, James McSwiggen, Dan T. Stinchcomb, James D. Thompson
  • Patent number: 6146886
    Abstract: A transcribed non-naturally occuring RNA molecule comprising a desired RNA molecule, wherein the 3' region of the RNA is able to base-pair with at least 8 bases at the 5' terminus of the same RNA molecule.
    Type: Grant
    Filed: August 7, 1995
    Date of Patent: November 14, 2000
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventor: James D. Thompson
  • Patent number: 6078287
    Abstract: A beam-forming network having a network of phase shifting devices that is independent from other parts of the beam-forming network. In one embodiment, the network of phase shifting devices has multiple layers between the power divider and power combiner layers. The multiple layers provide a selectable phase shift for each feed independent from the other feeds. In another embodiment, the network of phase shifting devices is one layer of commendable phase shifters. In any embodiment, the resulting composite beam has higher directivity and lower side lobes as compared to conventional beam-forming networks.
    Type: Grant
    Filed: August 13, 1999
    Date of Patent: June 20, 2000
    Assignee: Hughes Electronics Corporation
    Inventors: James D. Thompson, Steven O. Lane
  • Patent number: 5989906
    Abstract: An enzymatic RNA molecule which specifically cleaves mRNA encoded by an mdr-1 gene.
    Type: Grant
    Filed: February 7, 1994
    Date of Patent: November 23, 1999
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventor: James D. Thompson
  • Patent number: 5972704
    Abstract: An enzymatic nucleic acid molecule which cleaves an immunodeficiency virus RNA in a gene required for viral replication, e.g., the nef or tat gene regions.
    Type: Grant
    Filed: August 13, 1997
    Date of Patent: October 26, 1999
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Kenneth G. Draper, Bharat Chowrira, James McSwiggen, Dan T. Stinchcomb, James D. Thompson
  • Patent number: 5966048
    Abstract: Amplifier-induced intermodulation distortion (IMD) is reduced by encoding a multi-frequency input composite signal into multiple encoded signals that vary from each other in their power amplitudes as a function of frequency, amplifying the encoded signals, and then decoding them in a complementary fashion so as to differentiate between the amplified signal components and the IMD components. The amplified signal components are coherently combined to separate them from the IMD components, which are incoherently combined. The input signal is preferably encoded by dividng it into multiple divided signals, introducing relative phase shifts between the divided signals that vary as a function of frequency, and combining the divided and phase shifted signals with each other in a Butler matrix prior to amplification. The phase shifts are introduced by means of time delays that are preferably equal to integer multiples of 4.PI. divided by the input signal bandwidth.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: October 12, 1999
    Assignee: Hughes Electronics Corporation
    Inventor: James D. Thompson
  • Patent number: 5952902
    Abstract: A coaxial "M" switch having three coaxial input connectors (A, B, C) spaced evenly from each other, and three coaxial output connectors (1, 2, 3) identically arranged. In a cylindrical barrel embodiment (10) the input and output connectors are located at opposite ends of a cylindrical configuration. In one planar embodiment (30), the input and output connectors alternate with each other and define a hexagonal configuration (40). In another planar embodiment, the input connectors (A, B, C) define an inner triangular configuration (70) that is surrounded by the output connectors (1, 2, 3) defining an outer triangular configuration. In each embodiment, reeds are actuated in predetermined configurations to define three switch positions.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: September 14, 1999
    Inventors: Rolf Kich, Richard L. Bennett, David M. Kershner, James D. Thompson
  • Patent number: 5801158
    Abstract: An enzymatic RNA molecule which cleaves mRNA associated with development or maintenance of colon carcinoma.
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: September 1, 1998
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: James D. Thompson, Kenneth G. Draper
  • Patent number: 5768266
    Abstract: A mobile, satellite-based communication system includes a defined signaling arrangement developed from an analysis of factors including movement of the mobile terminals, movement of the satellite, beam discrepancies and duration of the call to the mobile terminal to set up a frame assignment plan for time division multiple access (TDMA) carriers and identifying permissible frame offset which can be accommodated throughout the entire transmission. As a result, timing and frequency references from a mobile to mobile command (MMC) may be provided from a reference source along with receive and transmit data communications without losing the command signals or the communication information and providing highly efficient use of each carriers time slots for receiving transmitting communication signals. Similarly, the signaling arrangement permits an efficient frame structure and a time slot assignment plan that does not require enhanced equipment at the mobile terminal.
    Type: Grant
    Filed: February 16, 1996
    Date of Patent: June 16, 1998
    Assignee: Hughes Electronics
    Inventors: James D. Thompson, Mohammad Soleimani, Jeffrey E. Outwater
  • Patent number: 5750390
    Abstract: An enzymatic RNA molecule which cleaves bcl.2 mRNA associated with development or maintenance of follicular lymphoma.
    Type: Grant
    Filed: August 26, 1992
    Date of Patent: May 12, 1998
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: James D. Thompson, Kenneth G. Draper
  • Patent number: 5714383
    Abstract: An enzymatic RNA molecule which cleaves mRNA associated with development or maintenance of CML.
    Type: Grant
    Filed: December 23, 1994
    Date of Patent: February 3, 1998
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventor: James D. Thompson
  • Patent number: 5693535
    Abstract: An enzymatic nucleic acid molecule which cleaves an immunodeficiency virus RNA in a gene required for viral replication, e.g., the nef or tat gene regions.
    Type: Grant
    Filed: July 7, 1994
    Date of Patent: December 2, 1997
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Kenneth G. Draper, Bharat Chowrira, James McSwiggen, Dan T. Stinchcomb, James D. Thompson
  • Patent number: 5639655
    Abstract: An enzymatic RNA molecule which cleaves mRNA associated with development or maintenance of promyelocytic leukemia.
    Type: Grant
    Filed: April 25, 1994
    Date of Patent: June 17, 1997
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: James D. Thompson, Kenneth G. Draper